glp 1 effect on mood Transformation 2.0: The GLP-1 RAs as Psychiatric Medications? GLP-1 Survey: 37.5% of People

Description

But the weight

What they found was cost dominates treatment decisions: 68% said cost influenced their decision to start or continue treatment 44% said the medication cost more than they expected Cost surpassed side effects as the #1 reason people stopped taking GLP-1s A breakdown of the financial burden: 24% pay more than $250 per prescription fill Nearly 8% pay $500 or more per fill 24% said insurance didn't cover any cost Weight management patients were nearly twice as likely to pay $250+ vs diabetes patients --- Here's what patients are thinking: Nearly 40% ended up using discount programs or manufacturer coupons 60% know someone who wants GLP-1s but can't afford them 83% believe Americans turn to DTC programs because traditional healthcare is too expensive Patients still prioritize safety: 60% are aware of safety risks with non-FDA-approved GLP-1s--this one surprised me

This review article examines the translational evolution of glucagon-like peptide-1 receptor agonists (GLP-1RAs), tracing their progression from the discovery of exendin-4 in Gila monster venom to long-acting peptide analogues and the first orally delivered peptide therapy, oral semaglutide

BALANCE HORMONES REGULATE BLOOD SUGAR OPTIMIZE INSULIN SENSITIVITY A groundbreaking handbook for activating your body's naturally occurring weight-loss hormones without relying on medication, from the former director at Novo Nordisk, the pharmaceutical company behind Wegovy and OzempicThe most important GLP-1 conv